Breaking News Instant updates and real-time market news.

AKTS

Akoustis

$4.91

-0.18 (-3.54%)

09:01
11/30/18
11/30
09:01
11/30/18
09:01

Akoustis initiated with a Buy at Lake Street

Lake Street analyst Jaeson Schmidt started Akoustis Technologies with a Buy rating and $10 price target. The company's "differentiated" products can help it gain share in the $5.4B bulk acoustic wave radio frequency filter market, Schmidt tells investors in a research note. He says Akoustis' expanding engagement pipeline will start to flow to profits in a "meaningful way" in the coming years.

  • 04

    Dec

  • 11

    Dec

  • 12

    Dec

AKTS Akoustis
$4.91

-0.18 (-3.54%)

11/01/18
LOOP
11/01/18
NO CHANGE
LOOP
Akoustis price target lowered to $11 from $15 at Loop Capital
Loop Capital analyst Cody Acree reiterated a Buy rating on Akoustis Technologies but lowered his price target on shares to $11 from $15. Acree noted that the company's "pullback since its recent financing provides it with the resources to accelerate its product development and capacity expansion efforts, and help its customers become more confident in its ability to reliably manufacture in high volumes." However, despite the reiterated Buy rating, the analyst lowered his price target due to multiple contractions across most of the semi group.
10/10/18
PIPR
10/10/18
INITIATION
Target $10
PIPR
Overweight
Akoustis initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Harsh Kumar started Akoustis Technologies with an Overweight rating and $10 price target. The analyst believes the company is well positioned to participate in the upcoming 5G cycle with its BAW filter portfolio. Akoustis's single crystal BAW filters offer several technological benefits over the current market offerings, Kumar tells investors in a research note.
09/24/18
LOOP
09/24/18
NO CHANGE
Target $15
LOOP
Buy
Akoustis on track to meet its targets, says Loop Capital
Loop Capital analyst Cody Acree kept his Buy rating and $15 price target on Akoustis after meeting with its management, saying the discussions added to his confidence of the company's ability to meet its WiFi, Radar, Infrastructure and Citizen Band Radio market targets. The analyst estimates that given its current headcount and a newly purchased fab in Canandaigua, New York, the company has the capacity to generate up to $200M in annual revenue.
08/30/18
08/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PayPal (PYPL) initiated with a Buy at Berenberg. 2. Akoustis (AKTS) initiated with an Outperform at Oppenheimer. 3. Adverum Biotechnologies (ADVM) initiated with a Buy at SunTrust. 4. Tocagen (TOCA) initiated with a Buy at Chardan. 5. Tandem Diabetes (TNDM) initiated with a Buy at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

GFF

Griffon

$21.98

-0.45 (-2.01%)

07:43
11/20/19
11/20
07:43
11/20/19
07:43
Conference/Events
Griffon management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GDDY

GoDaddy

$68.24

-0.05 (-0.07%)

07:42
11/20/19
11/20
07:42
11/20/19
07:42
Conference/Events
GoDaddy management to meet with Wedbush »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

TJX

TJX

$60.66

1.12 (1.88%)

07:42
11/20/19
11/20
07:42
11/20/19
07:42
Recommendations
TJX analyst commentary  »

TJX price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AMRN

Amarin

$22.74

0.11 (0.49%)

, MDCO

The Medicines Co.

$70.17

11.51 (19.62%)

07:41
11/20/19
11/20
07:41
11/20/19
07:41
Recommendations
Citi prefers Amarin shares to The Medicines Co. after this week's divergence »

Amarin (AMRN) shares this…

AMRN

Amarin

$22.74

0.11 (0.49%)

MDCO

The Medicines Co.

$70.17

11.51 (19.62%)

NVS

Novartis

$90.42

0.14 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 28

    Dec

FTDR

Frontdoor

$45.68

1.26 (2.84%)

07:41
11/20/19
11/20
07:41
11/20/19
07:41
Conference/Events
Frontdoor management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

RCI

Rogers Communications

$47.86

(0.00%)

, AMZN

Amazon.com

$1,752.17

-0.53 (-0.03%)

07:40
11/20/19
11/20
07:40
11/20/19
07:40
Hot Stocks
Rogers announces availability of Amazon Prime Video on Ignite TV »

Rogers (RCI) announced…

RCI

Rogers Communications

$47.86

(0.00%)

AMZN

Amazon.com

$1,752.17

-0.53 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RJF

Raymond James

$89.25

-0.06 (-0.07%)

07:40
11/20/19
11/20
07:40
11/20/19
07:40
Initiation
Raymond James initiated  »

Raymond James initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:40
11/20/19
11/20
07:40
11/20/19
07:40
General news
Treasury Market Outlook: yields continued to fall overnight »

Treasury Market Outlook:…

KSS

Kohl's

$47.01

-11.38 (-19.49%)

07:39
11/20/19
11/20
07:39
11/20/19
07:39
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FRPT

Freshpet

$54.37

-0.1 (-0.18%)

07:39
11/20/19
11/20
07:39
11/20/19
07:39
Conference/Events
Freshpet management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HLI

Houlihan Lokey

$47.69

0.18 (0.38%)

07:38
11/20/19
11/20
07:38
11/20/19
07:38
Initiation
Houlihan Lokey initiated  »

Houlihan Lokey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$16.43

0.335 (2.08%)

07:38
11/20/19
11/20
07:38
11/20/19
07:38
Conference/Events
Flexion management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HOLX

Hologic

$47.17

0.43 (0.92%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Hot Stocks
Hologic to sell its Cynosure business for $205M, to enter new $205M ASR »

Hologic announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTOO

T2 Biosystems

$1.82

0.07 (4.00%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Hot Stocks
T2 Biosystems announces granting of CE Mark for T2Resistance Panel »

T2 Biosystems and CARB-X…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$359.52

9.53 (2.72%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Recommendations
Tesla analyst commentary  »

Tesla's base…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAZ

Lazard

$37.61

0.12 (0.32%)

07:36
11/20/19
11/20
07:36
11/20/19
07:36
Initiation
Lazard initiated  »

Lazard initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AHC

A.H. Belo

$3.15

0.03 (0.96%)

07:35
11/20/19
11/20
07:35
11/20/19
07:35
Hot Stocks
A.H. Belo announces restatement, receives NYSE notice on late 10-Q filing »

A. H. Belo Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$36.21

0.04 (0.11%)

07:34
11/20/19
11/20
07:34
11/20/19
07:34
Hot Stocks
Pembina Pipeline's acquisition of Kinder Morgan Canada approved by CCB »

Pembina Pipeline and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVR

Evercore Partners

$76.43

0.64 (0.84%)

07:34
11/20/19
11/20
07:34
11/20/19
07:34
Initiation
Evercore Partners initiated  »

Evercore Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVUS

VIVUS

$2.84

0.09 (3.27%)

07:33
11/20/19
11/20
07:33
11/20/19
07:33
Hot Stocks
VIVUS announces results of clinical study of Qysmia in patients with BED, BN »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$115.83

2.19 (1.93%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Downgrade
Woodward rating change  »

Woodward downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

HOLX

Hologic

$47.17

0.43 (0.92%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Hot Stocks
Clayton, Dubilier & Rice to acquire Cynosure from Hologic »

Clayton, Dubilier &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.07

-0.05 (-0.11%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Recommendations
Endava analyst commentary  »

Endava price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

MYOS

MYOS

$1.49

(0.00%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Hot Stocks
MYOS' Fortetropin shows muscle increase in accepted clinical trial presentation »

MYOS RENS, owner of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCUR

Exicure

$2.60

0.13 (5.26%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Initiation
Exicure initiated  »

Guggenheim starts Exicure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.